A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma

Clinical trial NCT06761677 · SUSPENDED

Trial details

NCT number: NCT06761677
Sponsor: SymBio Pharmaceuticals
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed or Refractory Lymphoma Including ENKL

Start date: 2025-06-09
Primary completion: 2027-10-23
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.